In endeavors to identify biomarkers associated with the exacerbation or improvement of atopic dermatitis (AD), Ariëns et al. assessed twenty-one biomarkers linked to various AD pathways, including IL-4 and IL-13. The gene discussed is IL13; the disease is atopic eczema.